Multiple-plaintiff civil lawsuits, known as class actions, that claim a foreign company violated US trading laws rarely go to trial, so one that began last week in a New York federal court against two Chinese makers of raw vitamin C offers a chance to break legal ground.
An editor and writer at China Daily USA in New York, William Hennelly is a print and digital media veteran. He previously was managing editor of TheStreet.com financial news website in New York, and has worked at daily newspapers in New Jersey. Hennelly is a journalism graduate of Indiana University in Bloomington, Indiana.
General manager of China Daily USA's San Francisco bureau. Based in the Bay Area, she covers a wide range of topics including corporate news, Silicon Valley innovation, US-China cooperation in various forms and profiles of interesting personalities, as well as overseeing office operations.
Chen Weihua is the Chief Washington Correspondent of China Daily and Deputy Editor of China Daily USA. He is also a columnist, with a particular focus on US politics and US-China relations.
A copy editor and writer with China Daily USA in New York, Chris Davis is a graduate of the University of Virginia and served two years as a volunteer with the United States Peace Corps in Kenya.
US President Donald Trump visits China
